Vaccines are administered to healthy individuals, including vulnerable populations such as infants, pregnant women, and the elderly. Because of this, maintaining the highest standards of safety is paramount. Pharmacovigilance helps in monitoring the safety profile of vaccines post-licensure and identifying rare or long-term adverse events that may not have been evident during clinical trials.
